OptiBiotix Health plc (LON:OPTI) has announced the appointment of Steven Riley as head of online sales and marketing from May 2, to develop the company’s web presence.
The AIM-listed firm said Riley - who has over eight years' sales and marketing experience within the food, nutrition and nutraceuticals industries - will lead the development of the OptiBiotix online presence as another revenue generating business in its own right.
READ: OptiBiotix expands sales into Asia after inking five-year distribution deal with Pakistan pharma
The company said it will use the online platform as a display window to attract potential partners, as they did with GoFigure, which led to a deal with Tata Chemical for its SlimBiome product.
Optibiotix added: "The Company will extend its offering online with the CholBiome range that should enable it to attract further partners for LPLDL such as Trigen Pharma as announced on 18 April 2018."
Per Rehne, Optibiotix's commercial director said: "We want to develop this as display window to attract B2B partners and major retailers. This creates another channel for OptiBiotix that will generate revenues from OptiBiotix’s growing pipeline of products and we believe it has the potential to grow into a business in its own right.”